Global market valuation was derived through revenue mapping and digital health utilization volume analysis. The methodology included:
• Identification of over 50 critical stakeholders in North America, Europe, Asia-Pacific, and Latin America, including health analytics firms, telehealth platforms, RPM device manufacturers, and EHR vendors.
• Product and service mapping across telemedicine platforms, remote patient monitoring systems, health information exchanges, clinical decision support systems, wearable medical devices, mobile health applications, cloud computing infrastructure, and big data analytics tools
• Analysis of reported and modeled annual revenues specific to digital health portfolios, including software subscriptions, platform licensing, device sales, and service fees
• Coverage of stakeholders representing 75-80% of global market share in 2024
• Extrapolation using bottom-up (telehealth consultation volumes × average reimbursement rates by country; wearable device shipments × average selling price by region; cloud healthcare IT spending by provider type) and top-down (vendor revenue validation and healthcare IT budget allocation analysis) approaches to derive segment-specific valuations for service types, technologies, end-user categories, and deployment modes